Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Other Operating Expenses: 2011-2024

Historic Other Operating Expenses for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $29.5 million.

  • Niagen Bioscience's Other Operating Expenses rose 24.47% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.8 million, marking a year-over-year increase of 23.96%. This contributed to the annual value of $29.5 million for FY2024, which is 11.46% up from last year.
  • As of FY2024, Niagen Bioscience's Other Operating Expenses stood at $29.5 million, which was up 11.46% from $26.4 million recorded in FY2023.
  • Niagen Bioscience's Other Operating Expenses' 5-year high stood at $29.5 million during FY2024, with a 5-year trough of $20.9 million in FY2020.
  • Moreover, its 3-year median value for Other Operating Expenses was $28.3 million (2022), whereas its average is $28.1 million.
  • Per our database at Business Quant, Niagen Bioscience's Other Operating Expenses spiked by 35.34% in 2021 and then fell by 6.62% in 2023.
  • Niagen Bioscience's Other Operating Expenses (Yearly) stood at $20.9 million in 2020, then soared by 35.34% to $28.4 million in 2021, then fell by 0.14% to $28.3 million in 2022, then fell by 6.62% to $26.4 million in 2023, then climbed by 11.46% to $29.5 million in 2024.